Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/1997
10/23/1997WO1997038982A1 Novel carboxylic acid derivatives, their production and use
10/23/1997WO1997038981A1 NOVEL α-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE
10/23/1997WO1997038980A1 New carboxylic acid derivatives, their production and use
10/23/1997WO1997038665A2 Inhibitors of farnesyl-protein transferase
10/23/1997CA2251381A1 New carboxylic acid derivatives, their production and use
10/23/1997CA2250764A1 Novel carboxylic acid derivatives, their production and use
10/23/1997CA2250757A1 Novel .alpha.-hydroxylic acid derivatives, their production and use
10/23/1997CA2249601A1 Inhibitors of farnesyl-protein transferase
10/22/1997EP0802183A1 Estrogenic agents
10/22/1997EP0801656A1 Induction of cytotoxic t-lymphocyte responses
10/22/1997EP0801554A1 Formulations and methods for reducing skin irritation
10/22/1997EP0640080B1 Substituted indoles as angiotensin ii antagonists
10/22/1997CN1162488A Medicine for complicated urinary infection
10/22/1997CN1162485A Medicine for curing bilestone and biliary calculus
10/16/1997WO1997038002A1 Extracellular/epidermal growth factor-like protein
10/16/1997WO1997037995A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
10/16/1997WO1997037983A1 α1-ADRENERGIC RECEPTOR ANTAGONISTS
10/16/1997WO1997037979A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
10/16/1997WO1997037688A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
10/16/1997WO1997037678A1 Drug for the treatment of tumours
10/16/1997WO1997037666A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
10/16/1997WO1997037665A1 Method of treating heart failure with endothelin antagonists
10/16/1997WO1997022619A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
10/16/1997DE19614542A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use
10/16/1997DE19614534A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use
10/16/1997DE19614533A1 Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung New alpha-hydroxy-acid derivatives, their preparation and use
10/16/1997CA2650637A1 Pharmaceutical composition containing angiotensin ii antagonist
10/16/1997CA2251308A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
10/16/1997CA2251072A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
10/16/1997CA2250839A1 Drug for the treatment of tumours
10/16/1997CA2249213A1 Extracellular/epidermal growth factor-like protein
10/15/1997EP0801132A2 Staphylococcal FtsH protein
10/15/1997EP0801067A1 Novel quinuclidine derivatives and medicinal composition thereof
10/15/1997EP0801060A1 Heterocyclic Beta-3 Adrenergenic Agonists
10/15/1997EP0598770B1 New pyrazine derivatives, their preparation and their use
10/15/1997CN1162267A Methods and compositions for specific coagulation of vasculature
10/15/1997CN1161960A Ortho-substituted benzoylguanidine, preparation method, use as medicine or diagnostic reagent and medicine containing same
10/14/1997US5677451 Controlling cell differentiation; skin disorders; anticancer agents
10/14/1997US5677346 Treating urinary incontinence using (S)-desethyloxybutynin
10/14/1997US5677324 Benzopyranes as potassium channel openers
10/14/1997US5677321 Anesthetic premedication
10/14/1997US5677319 Thiazole derivative
10/14/1997US5677312 Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation
10/09/1997WO1997036906A1 Heterocyclic compounds and their preparation and use
10/09/1997WO1997036903A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
10/09/1997WO1997036901A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036900A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036898A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036897A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036896A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036892A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036891A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036890A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036889A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036888A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036886A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036879A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036877A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036876A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036874A1 Eprosartan dihydrate and a process for its production and formulation
10/09/1997WO1997036605A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036593A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036592A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036591A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036585A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036584A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997036583A1 Inhibitors of farnesyl-protein transferase
10/09/1997WO1997031941A3 Soluble tachykinin antagonists, the preparation and use thereof
10/09/1997DE19613691A1 Arzneimittel für die Behandlung von Tumorerkrankungen Drugs for the treatment of tumor diseases
10/09/1997CA2250937A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250936A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250843A1 Heterocyclic compounds and their preparation and use
10/09/1997CA2250587A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250460A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250353A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250209A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
10/09/1997CA2250204A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250203A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250192A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250190A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250143A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249665A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249650A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249645A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249641A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249617A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249615A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249607A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249605A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249604A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249599A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249559A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2201988A1 Heterocyclic .beta.-adrenergic agonists
10/08/1997EP0799619A2 Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and treatment of benign prostatic hyperplasia
10/08/1997EP0799058A1 Improvements in or relating to endometrial function
10/08/1997EP0799042A1 Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception
10/08/1997EP0655062B1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors
10/07/1997US5675008 Excitatory amino acid receptor antagonists
10/07/1997US5674909 For treatment of cardiovascular disorders
10/07/1997US5674895 Time-released mixture containing oxybutynin or salt, polyalkylene oxide, hydroxypropylalkylcellulose, lubricant; drug delivery
1 ... 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 ... 562